A Multicenter Study to Describe the Safety and Efficacy of Ceftaroline Fosamil in Elderly Subjects With Community-Acquired Bacterial Pneumonia
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 15 May 2015
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 08 Feb 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 22 Aug 2012 New trial record